163 related articles for article (PubMed ID: 18342376)
1. The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy.
Blankesteijn WM; van de Schans VA; ter Horst P; Smits JF
Trends Pharmacol Sci; 2008 Apr; 29(4):175-80. PubMed ID: 18342376
[TBL] [Abstract][Full Text] [Related]
2. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.
van de Schans VA; van den Borne SW; Strzelecka AE; Janssen BJ; van der Velden JL; Langen RC; Wynshaw-Boris A; Smits JF; Blankesteijn WM
Hypertension; 2007 Mar; 49(3):473-80. PubMed ID: 17210832
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
4. Cardiac hypertrophy and the Wnt/Frizzled pathway.
Cingolani OH
Hypertension; 2007 Mar; 49(3):427-8. PubMed ID: 17210831
[No Abstract] [Full Text] [Related]
5. Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning.
Barandon L; Dufourcq P; Costet P; Moreau C; Allières C; Daret D; Dos Santos P; Daniel Lamazière JM; Couffinhal T; Duplàa C
Circ Res; 2005 Jun; 96(12):1299-306. PubMed ID: 15920021
[TBL] [Abstract][Full Text] [Related]
6. An evolutionary conserved role of Wnt signaling in stem cell fate decision.
Teo R; Möhrlen F; Plickert G; Müller WA; Frank U
Dev Biol; 2006 Jan; 289(1):91-9. PubMed ID: 16309665
[TBL] [Abstract][Full Text] [Related]
7. The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe?
van de Schans VA; Smits JF; Blankesteijn WM
Eur J Pharmacol; 2008 May; 585(2-3):338-45. PubMed ID: 18417121
[TBL] [Abstract][Full Text] [Related]
8. Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer.
Liss MA; Schlicht M; Kahler A; Fitzgerald R; Thomassi T; Degueme A; Hessner M; Datta MW
Cancer Genomics Proteomics; 2010; 7(5):245-52. PubMed ID: 20952759
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
Oloumi A; Syam S; Dedhar S
Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
[TBL] [Abstract][Full Text] [Related]
10. CRH and SRIF have opposite effects on the Wnt/β-catenin signalling pathway through PKA/GSK-3β in corticotroph pituitary cells.
Khattak MN; Buchfelder M; Kleindienst A; Schöfl C; Kremenevskaja N
Cancer Invest; 2010 Oct; 28(8):797-805. PubMed ID: 20690801
[TBL] [Abstract][Full Text] [Related]
11. The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand?
ter Horst P; Smits JF; Blankesteijn WM
Acta Physiol (Oxf); 2012 Jan; 204(1):110-7. PubMed ID: 21624093
[TBL] [Abstract][Full Text] [Related]
12. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
[TBL] [Abstract][Full Text] [Related]
13. Wnt/beta-catenin pathway.
Moon RT
Sci STKE; 2005 Feb; 2005(271):cm1. PubMed ID: 15713948
[TBL] [Abstract][Full Text] [Related]
14. [Wnt signaling and glucocorticoid-induced osteoporosis].
Ohnaka K
Clin Calcium; 2006 Nov; 16(11):1812-6. PubMed ID: 17079847
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells.
Etheridge SL; Spencer GJ; Heath DJ; Genever PG
Stem Cells; 2004; 22(5):849-60. PubMed ID: 15342948
[TBL] [Abstract][Full Text] [Related]
16. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL
J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling.
Naito AT; Akazawa H; Takano H; Minamino T; Nagai T; Aburatani H; Komuro I
Circ Res; 2005 Jul; 97(2):144-51. PubMed ID: 15994435
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
19. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS
J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355
[TBL] [Abstract][Full Text] [Related]
20. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling.
Rao AS; Kremenevskaja N; Resch J; Brabant G
Eur J Endocrinol; 2005 Dec; 153(6):929-38. PubMed ID: 16322400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
